National Health Leaders Advocate Multi-Pronged Strategy for Cervical Cancer Elimination

At a national health consultation hosted in New Delhi, top medical professionals, public health experts, and government officials converged to establish a unified national framework for the elimination of cervical cancer across India. Highlighting the global 90–70–90 strategy outlined by the World Health Organization (WHO)—which targets 90% HPV vaccination coverage, 70% screening rates, and 90% timely treatment access—delegates called for a rapid transition toward advanced HPV DNA screening technologies. Public health experts emphasized that expanding localized, community-centered screening programs and introducing digital patient-tracking systems are vital to bridging the gap between early diagnostic detection and completed treatment pathways. The consultative panel stressed the urgency of deploying indigenous diagnostic platforms, expanding frontline healthcare worker training, and ensuring equitable medical access for rural and underserved female populations. Medical researchers noted that combining high-volume vaccination drives with systematic screening networks will drastically reduce cervical cancer mortality rates, positioning India as a regional leader in preventive women's healthcare and oncological management.

National Dialogue Series Calls for Multi-Sectoral Consensus

In a major public health assembly held in New Delhi, national health leaders, oncologists, researchers, and policy architects called for an integrated, multi-pronged response to accelerate the elimination of cervical cancer across India. Convened by the Cancer Awareness Prevention and Early Detection (CAPED) Trust alongside the National Cancer Institute (NCI-AIIMS) and ICMR-National Institute of Cancer Prevention and Research (NICPR), the two-day summit brought together government representatives, medical societies, and international partners to bridge implementation gaps between screening, diagnosis, and long-term care pathways.

Overview: Key Strategic Pillars for National Cervical Cancer Elimination

Strategic Focus Area	Operational Framework & Key Target Specifications
Global Elimination Standard	WHO 90–70–90 Targets by 2030 (Vaccination, Screening, & Treatment)
Primary Prevention	Expanded HPV Vaccination for adolescent girls
Screening Methodology	Transitioning to HPV DNA-based testing & self-sampling kits
Actionable Framework	S-A-V-E (Screening, Access to Treatment, Vaccination, & Empowerment)
Digital tracking	Deployment of systems like PRAVAAH for patient pathway monitoring
Community Infrastructure	Addressing social stigma, referral drop-offs, and localized care

Aligning National Action with WHO '90–70–90' Goals

Central to the consultation was an explicit push to operationalize the World Health Organization’s (WHO) global 90–70–90 targets within India's primary health architecture: fully vaccinating 90% of girls with the HPV vaccine by age 15, screening 70% of eligible women using high-performance tests, and providing timely treatment to 90% of women diagnosed with precancer or invasive lesions. Speakers underscored that while single-dose HPV vaccination drives represent major progress, long-term elimination requires simultaneous investment in high-sensitivity diagnostic infrastructure.

Health leaders urged a paradigm shift toward advanced HPV DNA-based screening, highlighting its higher clinical sensitivity compared to conventional visual inspection techniques. To overcome cultural and logistical barriers in rural and underserved communities, experts advocated for community-based HPV self-sampling and extended-genotyping hub-and-spoke models. These innovations allow women to collect samples safely at local Ayushman Arogya Mandirs or at home, drastically reducing drop-off rates across diagnostic referral chains.

Digital Patient Pathways and Multi-Stakeholder Financing

To prevent follow-up failures after positive screening results, academic institutions and tech partners presented digital tracking frameworks, including the PRAVAAH digital patient-pathway model developed at IIT Delhi. The system tracks individual patients from initial screening through confirmatory triage and treatment, ensuring continuous care.

Concluding the summit, delegates articulated the S-A-V-E implementation framework: Screening with advanced technology, Access to timely treatment, Vaccination expansion, and Empowering communities against social stigma. Leaders emphasized that fulfilling this mandate requires coordinated corporate social responsibility (CSR) investments, public-private partnerships, and state-level policy integration to ensure equitable access for women nationwide.